��TV

About

��TV is a clinical-stage biotech company advancing novel antigen modulation ��TVs.

Our mission is to deliver a new class of ��TVs to improve the lives of people with cancers and autoimmune disorders.

Headquartered in Oxford, UK

Oral small molecules in Phase 1/2 trials

Founded in 2017 by Peter Joyce, former R&D Lead at Vertex Pharmaceuticals, and Tom McCarthy, former President and CEO of Spinifex Pharmaceuticals (acquired by Novartis for ~$700M).

Leadership

Chief Executive Officer & Co-founder

Head of Finance

Chief Medical Officer

Chief Business Officer

Chief Operating Officer

We're looking for talented individuals to join our award-winning team. Do you have what it takes?

Our board

Chief Executive Officer, Co-founder

Non-Executive Director & Co-founder

Allan Marchington

Managing Director, Head of Life Sciences

Raphaël Wisniewski

Partner at Andera Partners (BioDiscovery)

Katya Smirnyagina

Senior Partner at Oxford Science Enterprises

Thierry Hercend

Industry Expert Director

Rabab Nasrallah

Investment Professional at Earlybird VC

Marie-Claire Peakman

Partner at Pfizer Ventures

General Partner at Canaan (West Coast)

Testimonials

"��TV are doing incredible things and they are totally going to change the game - best thing since sliced bread."

Big Time Existing Investor

Partner, Acme Investment

Awards

Best Biomedical Product
(2025 finalist)

Biotech of the Year
(2025 & 2026 winner)

Best Established Biotech
(2024 & 2025 finalist)

Series B Raise of the Year
(2024 finalist)

Existing investors

We are funded by high quality investors.

Discover how our therapies are reshaping ��TV for various diseases and conditions.

Follow our news and events.